190 related articles for article (PubMed ID: 30554075)
1. Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide.
Rios A; Cen P; Dinh B; Mays SR; Patel AB
Eur J Cancer; 2019 Jan; 107():97-99. PubMed ID: 30554075
[No Abstract] [Full Text] [Related]
2. A Psoriasiform Drug Eruption Secondary to Nivolumab for Hepatocellular Carcinoma: A Case Report.
Stotts MJ; Adjapong O; Kaplan DE
Hepatology; 2019 Oct; 70(4):1477-1479. PubMed ID: 31004512
[No Abstract] [Full Text] [Related]
3. Multiple Cranial Neuropathies From Nivolumab in a Patient With Metastatic Hepatocellular Carcinoma.
Siegel CH; Finn RS; Ho MG
Mayo Clin Proc; 2018 Apr; 93(4):540-541. PubMed ID: 29622100
[No Abstract] [Full Text] [Related]
4. Late-onset Stevens-Johnson syndrome due to nivolumab use for hepatocellular carcinoma.
Dasanu CA
J Oncol Pharm Pract; 2019 Dec; 25(8):2052-2055. PubMed ID: 30782092
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast.
Fattore D; Annunziata MC; Panariello L; Marasca C; Fabbrocini G
Eur J Cancer; 2019 Mar; 110():107-109. PubMed ID: 30785013
[No Abstract] [Full Text] [Related]
6. Gastric necrosis after nivolumab therapy in a patient with advanced hepatocellular carcinoma.
Hsu WF; Lin YC; Chiang IP; Peng CY
Dig Liver Dis; 2021 Nov; 53(11):1506-1507. PubMed ID: 32928671
[No Abstract] [Full Text] [Related]
7. Treatment with pembrolizumab after hypersensitivity reaction to nivolumab in a patient with hepatocellular carcinoma.
Choi B; McBride A; Scott AJ
Am J Health Syst Pharm; 2019 Oct; 76(21):1749-1752. PubMed ID: 31612928
[TBL] [Abstract][Full Text] [Related]
8. Nivolumab for the treatment of hepatocellular carcinoma.
Finkelmeier F; Waidmann O; Trojan J
Expert Rev Anticancer Ther; 2018 Dec; 18(12):1169-1175. PubMed ID: 30304963
[TBL] [Abstract][Full Text] [Related]
9. Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers.
Finkelmeier F; Czauderna C; Perkhofer L; Ettrich TJ; Trojan J; Weinmann A; Marquardt JU; Vermehren J; Waidmann O
J Cancer Res Clin Oncol; 2019 Jan; 145(1):253-259. PubMed ID: 30374657
[TBL] [Abstract][Full Text] [Related]
10. Severe de-novo palmoplantar and nail psoriasis complicating Nivolumab treatment for metastatic melanoma.
Di Altobrando A; Bruni F; Alessandrini A; Starace M; Misciali C; Piraccini BM
Dermatol Ther; 2020 May; 33(3):e13363. PubMed ID: 32239596
[TBL] [Abstract][Full Text] [Related]
11. Acute-onset diabetes mellitus with ketoacidosis in a nivolumab-treated patient with hepatocellular carcinoma.
Harsch IA; Konturek PC
Wiad Lek; 2018; 71(5):945-948. PubMed ID: 30176620
[TBL] [Abstract][Full Text] [Related]
12. Herpes zoster granulomatous dermatitis in metastatic lung cancer treated with nivolumab: A case report.
Gozzi E; Rossi L; Angelini F; Leoni V; Trenta P; Cimino G; Tomao S
Thorac Cancer; 2020 May; 11(5):1330-1333. PubMed ID: 32141197
[TBL] [Abstract][Full Text] [Related]
13. [Varied immuno-related adverse events induced by immune-check point inhibitors - Nivolumab-associated psoriasiform dermatitis related with increased serum level of interleukin-6].
Okiyama N; Tanaka R
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(2):95-101. PubMed ID: 28603207
[TBL] [Abstract][Full Text] [Related]
14. Eczematous reactions mimicking psoriasiform dermatitis induced by nivolumab for advanced lung cancer.
Tanaka M; Hoashi T; Ichiyama S; Noro R; Seike M; Kubota K; Gemma A; Funasaka Y; Saeki H
Australas J Dermatol; 2019 Feb; 60(1):e67-e68. PubMed ID: 29896926
[No Abstract] [Full Text] [Related]
15. Histologically-diagnosed psoriasiform dermatitis induced by nivolumab successfully controlled by etanercept: A case report.
Kim YE; Kim TM; Jo SJ
J Dermatol; 2019 Dec; 46(12):e464-e466. PubMed ID: 31531885
[No Abstract] [Full Text] [Related]
16. New onset of psoriasis during nivolumab treatment for lung cancer.
Chujo S; Asahina A; Itoh Y; Kobayashi K; Sueki H; Ishiji T; Umezawa Y; Nakagawa H
J Dermatol; 2018 Mar; 45(3):e55-e56. PubMed ID: 29205470
[No Abstract] [Full Text] [Related]
17. August 2021: Treatment of psoriasis associated with nivolumab.
Sloan B
J Am Acad Dermatol; 2021 Aug; 85(2):317. PubMed ID: 34052333
[No Abstract] [Full Text] [Related]
18. [Initially undetected de novo psoriasis triggered by nivolumab for metastatic base of the tongue carcinoma].
Troyanova-Slavkova S; Eickenscheidt L; Dumann K; Kowalzick L
Hautarzt; 2018 Aug; 69(8):674-680. PubMed ID: 29330579
[TBL] [Abstract][Full Text] [Related]
19. Durable Complete Response of Brain Metastasis From Hepatocellular Carcinoma On Treatment With Nivolumab and Radiation Treatment.
Ye L; Zhang C; Seidensticker M; Mayerle J; Reiter FP; De Toni EN
Am J Gastroenterol; 2020 Dec; 115(12):2114-2116. PubMed ID: 32852335
[No Abstract] [Full Text] [Related]
20. PD-1 inhibitors monotherapy in hepatocellular carcinoma: Meta-analysis and systematic review.
Voutsadakis IA
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):505-510. PubMed ID: 31551142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
